LeonaBio (LONA) Cash from Financing Activities (2019 - 2025)
LeonaBio (LONA) reported Cash from Financing Activities of $82.4 million for Q4 2025, up 242361.76% year-over-year from N/an in Q4 2024, and up 242361.76% on a QoQ basis from $34000.0 in Q4 2024.
LeonaBio (LONA) has 7 years of Cash from Financing Activities data on file, last reported at $82.4 million in Q4 2025.
- Quarterly Cash from Financing Activities rose 242361.76% year-over-year to $82.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $82.5 million (up 41558.08% YoY) and the FY2025 annual result came in at $82.5 million, up 42405.67% from the prior year.
- Cash from Financing Activities rose to $82.4 million in Q4 2025 per LONA's latest filing, from $34000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $97.2 million in Q1 2021 and bottomed at -$260000.0 in Q2 2021.
- The 5-year median for Cash from Financing Activities is $147000.0 (2022), against an average of $13.9 million.
- The widest annual swing landed in 2021, when Cash from Financing Activities tumbled 100.3%; it then jumped 242361.76% in 2025.
- Tracing LONA's Cash from Financing Activities over 5 years: stood at $13000.0 in 2021, then jumped by 1030.77% to $147000.0 in 2022, then gained by 3.4% to $152000.0 in 2023, then sank by 77.63% to $34000.0 in 2024, then jumped by 242361.76% to $82.4 million in 2025.
- Per Business Quant, the three latest LONA Cash from Financing Activities figures stand at $82.4 million (Q4 2025), $34000.0 (Q4 2024), and $12000.0 (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 15.71 Mn |
| 10 | LeonaBio | 181.52 Mn | 113.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 82.44 Mn |
| Dec 31, 2025 | 82.44 Mn |
| Dec 31, 2024 | 34,000.00 |
| Dec 31, 2024 | 34,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Dec 31, 2023 | 152,000.00 |
| Dec 31, 2023 | 152,000.00 |
| Jun 30, 2023 | 242,000.00 |
| Jun 30, 2023 | 242,000.00 |
| Mar 31, 2023 | 99,000.00 |
| Mar 31, 2023 | 99,000.00 |
| Dec 31, 2022 | 147,000.00 |
| Dec 31, 2022 | 147,000.00 |
| Jun 30, 2022 | 297,000.00 |
| Jun 30, 2022 | 297,000.00 |
| Mar 31, 2022 | 210,000.00 |
| Mar 31, 2022 | 210,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Sep 30, 2021 | 125,000.00 |
| Sep 30, 2021 | 125,000.00 |
| Jun 30, 2021 | -260,000.00 |
| Jun 30, 2021 | -260,000.00 |
| Mar 31, 2021 | 97.21 Mn |
| Mar 31, 2021 | 97.21 Mn |
| Dec 31, 2020 | 21.32 Mn |
| Dec 31, 2020 | 21.32 Mn |
| Sep 30, 2020 | 184.28 Mn |
| Sep 30, 2020 | 184.28 Mn |
| Jun 30, 2020 | 85.30 Mn |
| Jun 30, 2020 | 85.30 Mn |
| Mar 31, 2020 | 1.84 Mn |
| Mar 31, 2020 | 1.84 Mn |
| Dec 31, 2019 | 54,000.00 |
| Dec 31, 2019 | 54,000.00 |